These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18467906)

  • 21. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease—from mechanisms to treatment strategies.
    Melgar S; Shanahan F
    Autoimmunity; 2010 Nov; 43(7):463-77. PubMed ID: 20388058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of inflammatory bowel disease.
    Siegmund B; Zeitz M
    Eur J Immunol; 2009 Aug; 39(8):2026-30. PubMed ID: 19672897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
    Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
    J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection.
    Lidar M; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Sep; 11(9):558-63. PubMed ID: 19960852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of a nursing model to understand diarrhea and the role of probiotics in patients with inflammatory bowel disease.
    Savard J; Sawatzky JA
    Gastroenterol Nurs; 2007; 30(6):418-23; quiz 424-5. PubMed ID: 18156958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Of mice and men: what to learn about human inflammatory bowel disease from genetic analysis of murine inflammation.
    Schreiber S
    Gastroenterology; 2005 Nov; 129(5):1782-4. PubMed ID: 16285973
    [No Abstract]   [Full Text] [Related]  

  • 30. Animal models of inflammatory bowel disease.
    Banić M; Anić B; Brkić T
    Acta Med Croatica; 1997; 51(1):37-40. PubMed ID: 9115101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?
    Fiocchi C
    Dig Dis; 2009; 27(3):226-35. PubMed ID: 19786745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Animal models of intestinal inflammation].
    Morteau O; Bueno L
    Gastroenterol Clin Biol; 1995 Feb; 19(2):204-14. PubMed ID: 7750711
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice.
    Amini-Shirazi N; Hoseini A; Ranjbar A; Mohammadirad A; Khoshakhlagh P; Yasa N; Abdollahi M
    Toxicol Mech Methods; 2009 Feb; 19(2):183-9. PubMed ID: 19778264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes.
    Barclay AR; Morrison DJ; Weaver LT
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):486-95. PubMed ID: 18493202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP; Ebert B; Martin HJ; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
    Uhlig HH; Powrie F
    Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
    Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
    Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?
    Kruidenier L; Verspaget HW
    Mediators Inflamm; 1998; 7(3):157-62. PubMed ID: 9705602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumonia in BALB/c Rag2-/- mice used in a CD45RB(high) T-cell transfer model of inflammatory bowel disease.
    Schoeb TR
    Vet Pathol; 2008 May; 45(3):427-9. PubMed ID: 18487506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.